Corrie, P. G. (2019). Cytotoxic chemotherapy : Clinical aspects. Medicine (Baltimore), 36(1), 24–28.
Sonis, B. S. T., & Fey, E. G. (2002). Oral complications of cancer therapy. Oncology, 16, 680–695.
Maree, J. E., Combrink, M. J., de Lange, T., Toerien, A. S., & Bedeker, M. (2012). Incidence, severity, and management of cancer chemotherapy-related oral mucositis in eastern cape and Western cape. Heal SA, 17(1), 632 1–632 7.
Peterson, D. E., Bensadoun, R. J., Roila, F., & O. behalf of the E. guidelines working Group (2010). Management of oral and gastrointestinal mucositis: ESMO clinical recommendations. Annals of Oncology, 20(Supplement 4), v261–v265.
D’Hondt, L., Christophe, L., Marc, A., & Jean-Luc, C. (2006). Oral mucositis induced by anticancer treatments : Physiopathology and treatments. Therapeutics and Clinical Risk Management, 2(2), 159–168.
Riley, P., Am, G., Hv, W., Littlewood, A., Je, C., & Mg, M. (2015). Interventions for preventing oral mucositis in patients with cancer receiving treatment : Oral cryotherapy ( review ) SUMMARY OF FINDINGS FOR THE MAIN COMPARISON. Cochrane Database of Systematic Reviews, 12, CD011552.
Cheng, K., Fong, K., et al. (2011). Incidence and risk factors of oral mucositis in pediatric and adolescent patients undergoing chemotherapy. Oral Oncology, 47(3), 153–162.
Çakmak, S., & Nural, N. (2019). Incidence of and risk factors for the development of oral mucositis in outpatients undergoing cancer chemotherapy. International Journal of Nursing Practice, 25(1), 1–9.
Jagwe, J., & Merriman, A. (2007). Uganda : Delivering analgesia in rural Africa : Opioid availability and nurse prescribing. Journal of Pain and Symptom Management, 33(5), 547–551.
Orem, J., & Wabinga, H. (2009). The roles of national cancer research institutions in evolving a comprehensive cancer control program in a developing country: Experience from Uganda. Oncology, 77(5), 272–280.
Wampaalu, P. B., Eriksson, L. E., Naamala, A., Nabirye, R. C., & Wettergren, L. (2016). Experiences of patients undergoing chemotherapy - a qualitative study of adults attending Uganda cancer institute. African Health Sciences, 16(3), 744–749.
Masika, G. M., Wettergren, L., Kohi, T. W., & Von Essen, L. (2012). Health-related quality of life and needs of care and support of adult Tanzanians with cancer : A mixed-methods study. Health and Quality of Life Outcomes, 10(133), 1–10.
Corner, J., Wagland, R., Glaser, A., & Richards, S. M. (2013). Qualitative analysis of patients ’ feedback from a PROMs survey of cancer patients in England. BMJ Open, 3, e002316.
Al-Rhudayni, A. H. M., Gopinath, D., Maharajan, M. K., & Menon, R. K. (2020). Impact of oral mucositis on quality of life systematic review.Pdf. Translational Lung Cancer Research, 9(4), 3126–3134.
Zanolin, D., Widmer, C., & Panfil, E.-M. (2014). Patients experiences with oral mucositis by chemotherapy. Nursing Reports, 4, 3647.
Graupner, C., et al. (2021). Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures ( PROMs ) in cancer care : A systematic review. Support Care Cancer, 29, 573–593.
Sonis, S., Edwards, L., & Lucey, C. (1999). The biological basis for the attenuation of mucositis : The example of interleukin-11. Leukemia, 13, 831–834.
Gussgard, A. M., Hope, A. J., Jokstad, A., Tenenbaum, H., & Wood, R. (2014). Assessment of cancer therapy-induced Oral Mucositis using a patient-reported Oral Mucositis experience questionnaire. PLoS One, 9(3), e91773.
Fusch, P., Fusch, G. E., & Ness, L. R. (2018). Denzin ’ s paradigm shift : Revisiting triangulation in qualitative. Journal of Social Changes, 10(1), 19–32.
Vickie, L. A., & Clinton, L. E. (2012). Editorial : Qualitative descriptive research : An acceptable design. Pacific Rim International Journal of Nursing Research, 16(4), 255–256.
Thomas, D. R. (2006). A general inductive approach for analyzing qualitative evaluation data. American Journal of Evaluation, 27(2), 237–246.
Whitford, H. S., & Olver, I. N. (2019). When expectations predict experience : The influence of psychological factors on chemotherapy toxicities. Journal of Pain and Symptom Management, 43(6), 1036–1050.
Öhrn, K. E. O., & Sjoden, P. O. (2003). Experiences of oral care in patients with hematological malignancies or head and neck cancer. European Journal of Cancer, 12, 274–282.
Rathee, M., Bhoria, M., & Dua, M. (2015). Multidisciplinary Oral Management in Cancer Therapy Part II : During cancer treatment. International Journal of Sciences: Basic and Applied Research, 22(2), 406–411.
Saito, H., Watanabe, Y., & Sato, K. (2014). Effects of professional oral health care on reducing the risk of chemotherapy-induced oral mucositis. Support Care Cancer, 22, 2935–2940.
Green, R., Horn, H., & Erickson, J. M. (2010). Eating experiences of children and adolescents with chemotherapy-related nausea and Mucositis. Journal of Pediatric Oncology Nursing, 27(4), 209-216.
Musumari, P. M., et al. (2014). Food insecurity is associated with increased risk of non- adherence to antiretroviral therapy among HIV-infected adults in the Democratic Republic of Congo : A cross-sectional study. PLoS One, 9(1), e85327.
Ravasco, P., Monteiro-Grillo, I., Vidal, P. M., & Camilo, M. E. (2005). Impact of nutrition on outcome : A prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head & Neck, 27(August), 659–668.
Gany, F., et al. (2016). Do our patients have enough to eat? Food insecurity among urban low-income cancer patients. Journal of Health Care for the Poor, 25(3), 1153–1168.
Carlotto, A., Hogsett, V. L., Maiorini, E. M., Razulis, J. G., & Sonis, S. T. (2013). The economic burden of toxicities associated with cancer treatment: Review of the literature and analysis of nausea and vomiting, diarrhea, oral mucositis and fatigue. Pharmacoeconomics, 31(9), 753–766.
Orem, J. N., & Zikusooka, C. M. (2010). Health financing reform in Uganda : How equitable is the proposed National Health Insurance scheme ? International Journal for Equity in Health, 9, 23.
Mika, M. (2017). Fifty years of creativity, crisis, and cancer in Uganda. Canadian Journal of African Studies / Revue Canadienne des Études Africaines, 50(3), 395–413.
Rubenstein, E. B., et al. (2004). Clinical practice guidelines for the prevention and treatment of cancer therapy – Induced Oral and gastrointestinal Mucositis. Cancer, 100(9 Suppl), 2026–2046.
Freyer, C., et al. (2019). Leucovorin following methotrexate graft-Vs-host disease prophylaxis shortens the duration of Mucositis, time to neutrophil engraftment and length of hospitalization in Myeloablative allogeneic hematopoietic transplantation. Biology of Blood and Marrow Transplantation, 25(3), S283.
Worthington, H. V., et al. (2011). Interventions for preventing oral mucositis for patients with cancer receiving treatment ( review ). Cochrane Database of Systematic Reviews, 4, CD000978.
Buentzel, J., Bauer, C., & Buentzel, J. (2020). How to bridge the gap ? European medical plants used for treating oral mucositis : On the search for evidence. Journal of Cancer Research and Clinical Oncology, 146(4), 985–1001.
Meyer-Hamme, G., et al. (2013). A survey of Chinese medicinal herbal treatment for chemotherapy-induced Oral Mucositis, (vol. 2013).
Berger, K., et al. (2018). Burden of Oral Mucositis : A systematic review and implications for future research. Oncology Research and Treatment, 41, 399–405.
Peach, M. S., et al. (2018). Patient-reported outcomes in head and neck cancer : Prospective multi-institutional patient-reported toxicity. Patient Related Outcome Measures, 9, 245–252.